⚠️ This provider averages 747 services per working day — physically unusual for an individual practitioner
Based on 1.9M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $21.0M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 747 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 126% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 80% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $42.69 | $14.64 | 2.92x | $28.05 | $1.3M | 89.4K | 46 |
| 2015 | $32.39 | $10.31 | 3.14x | $22.08 | $1.1M | 110.3K | 50 |
| 2016 | $31.48 | $9.40 | 3.35x | $22.08 | $2.1M | 218.2K | 54 |
| 2017 | $40.59 | $12.22 | 3.32x | $28.37 | $2.0M | 162.2K | 51 |
| 2018 | $38.29 | $11.71 | 3.27x | $26.58 | $1.9M | 158.9K | 54 |
| 2019 | $34.55 | $11.16 | 3.10x | $23.39 | $2.4M | 211.9K | 53 |
| 2020 | $37.06 | $10.94 | 3.39x | $26.12 | $2.5M | 226.6K | 57 |
| 2021 | $28.53 | $8.64 | 3.30x | $19.89 | $2.2M | 252.5K | 54 |
| 2022 | $34.45 | $10.31 | 3.34x | $24.14 | $2.7M | 262.4K | 56 |
| 2023 | $53.99 | $16.84 | 3.21x | $37.15 | $3.0M | 175.7K | 36 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 80.1K | $2.9M | $36.57 | 3.01x |
| J9271 | Injection, pembrolizumab, 1 mg | 40.4K | $1.7M | $41.93 | 3.12x |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 43.0K | $1.5M | $33.95 | 3.00x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 16.2K | $1.4M | $89.14 | 3.13x |
| J0897 | Injection, denosumab, 1 mg | 82.7K | $1.2M | $14.91 | 2.79x |
| J2505 | Injection, pegfilgrastim, 6 mg | 380 | $1.2M | $3.1K | 2.74x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 119.6K | $1.0M | $8.54 | 2.78x |
| J3380 | Injection, vedolizumab, 1 mg | 65.7K | $940.2K | $14.31 | 4.54x |
| J9145 | Injection, daratumumab, 10 mg | 18.4K | $780.6K | $42.47 | 2.78x |
| J9035 | Injection, bevacizumab, 10 mg | 12.7K | $771.1K | $60.52 | 2.79x |
| J9041 | Injection, bortezomib (velcade), 0.1 mg | 21.1K | $758.3K | $35.99 | 2.61x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 4.9K | $547.8K | $112.45 | 3.57x |
| J9310 | Injection, rituximab, 100 mg | 844 | $523.0K | $619.62 | 2.60x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 5.3K | $344.7K | $65.38 | 3.27x |
| J9999 | Not otherwise classified, antineoplastic drugs | 8.7K | $326.6K | $37.53 | 5.32x |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 442.7K | $316.5K | $0.72 | 3.67x |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 313 | $286.1K | $914.19 | 3.51x |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 8.5K | $263.3K | $30.81 | 3.08x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 27.3K | $242.7K | $8.87 | 3.27x |
| J9305 | Injection, pemetrexed, 10 mg | 4.5K | $213.0K | $47.13 | 2.63x |
This provider submits charges 3.25 times higher than what Medicare actually pays.
A markup ratio of 3.25x means for every $100 Medicare pays, this provider initially charges $325. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in FL for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Christopher Lobo, MD | Port Charlotte, FL | $60.5M | ⚠️ Flagged |
| Maen Hussein, M.D. | Tavares, FL | $57.6M | ✓ Clear |
| Vikas Malhotra, M.D. | Spring Hill, FL | $52.8M | ✓ Clear |
| Andrew Lipman, M.D. | Naples, FL | $51.1M | ⚠️ Flagged |
| Syed Zafar, M.D. | Fort Myers, FL | $48.1M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data